BHWM
TEVA icon

Bar Harbor Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bar Harbor Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-9,582
Closed -$307K – 329
2017
Q1 		$307K Sell
9,582
-4,978
-34% -$170K 0.04% 252
2016
Q4 		$528K Sell
14,560
-975
-6% -$38.9K 0.06% 205
2016
Q3 		$714K Buy
15,535
+1,100
+8% +$57.4K 0.08% 177
2016
Q2 		$725K Sell
14,435
-62
-0.4% -$3.3K 0.08% 169
2016
Q1 		$776K Sell
14,497
-552
-4% -$32.4K 0.09% 158
2015
Q4 		$988K Sell
15,049
-180
-1% -$11.1K 0.12% 133
2015
Q3 		$860K Sell
15,229
-1,955
-11% -$127K 0.11% 136
2015
Q2 		$1.01M Sell
17,184
-450
-3% -$27.8K 0.12% 128
2015
Q1 		$1.1M Buy
17,634
+55
+0.3% +$3.2K 0.13% 120
2014
Q4 		$1.01M Buy
17,579
+625
+4% +$34.8K 0.13% 124
2014
Q3 		$911K Sell
16,954
-135
-0.8% -$7.15K 0.12% 127
2014
Q2 		$895K Sell
17,089
-75
-0.4% -$3.83K 0.11% 134
2014
Q1 		$907K Sell
17,164
-375
-2% -$17.3K 0.12% 131
2013
Q4 		$703K Sell
17,539
-1,041
-6% -$41K 0.09% 154
2013
Q3 		$702K Sell
18,580
-1,040
-5% -$40.6K 0.1% 151
2013
Q2 		$769K Buy
+19,620
New +$764K 0.11% 137

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bar Harbor Wealth Management's TEVA Position: Q2 2017 in Review

Bar Harbor Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 9,582 shares — an estimated $307K sold.

Bar Harbor Wealth Management first reported a position in TEVA in Q2 2013 and held it in 16 quarters. The position peaked at $1.1M in Q1 2015. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Bar Harbor Wealth Management reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Bar Harbor Wealth Management sold 9,582 Teva Pharmaceuticals shares in Q2 2017, an estimated $307K.
  • Bar Harbor Wealth Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Bar Harbor Wealth Management's Teva Pharmaceuticals position peaked at $1.1M in Q1 2015.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Bar Harbor Wealth Management's 13F filing for Q2 2017, filed 10 Jul 2017.